ReviewTherapeutics and clinical risk management2017

Renal safety of tenofovir and/or entecavir in patients with chronic HBV monoinfection.

Young-Mo Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.